14C-Glucosamineの胃粘膜および肝組織への取込みとその消退に対する3,4,5-Trimethoxy-N-(3-piperidyl)benzamide(KU-54)の影響
スポンサーリンク
概要
- 論文の詳細を見る
Effects of KU-54 on the biosynthesis of glycoprotein in the gastric mucosa and the liver, as measured by the rate of incorporation of <SUP>14</SUP>C-glucosamine, were investigated in rats under various conditions after a single administration of <SUP>14</SUP>C-glucosamine (9.88 μCi/animal, ip). <SUP>14</SUP>C-glucosamine was incorporated with relative ease in the acid-insoluble fraction of the gastric mucosa. KU-54 at 100 mg/kg was orally administered twice daily for 5 days in rats (though it was given once on the 5 th day) before injection of <SUP>14</SUP>C-glucosamine. The rate of <SUP>14</SUP>C-glucosamine incorporation into the acid-insoluble fraction of the gastric mucosa was significantly increased by KU-54, but that of the hepatic tissue was not increased. In addition, hydrocortisone (20 mg/kg) also produced a drop of incorporation of <SUP>14</SUP>C-glucosamine in the gastric mucosa, but oral KU-54 at 100 mg/kg twice daily for 5 days (though it was given once on the 5 th day) significantly inhibited the drop of incorporation of <SUP>14</SUP>C-glucosamine in the gastric mucosa, but that in the hepatic tissue was not inhibited. Therefore, the effects of KU-54 were greater in the gastric mucosa than in the hepatic tissue. On the 5 th day of the ulcer produced by acetic acid in rats, the specific radioactivity in the mucosa of the margin of the ulcer increased significantly compared with that in the normal (non-ulcerative) mucosa, but this phenomenon was not affected by KU-54. On the 10 th day of the ulcer produced by acetic acid, the increase of specific radioactivity in the marginal mucosa disappeared in the control group; but in the KU-54 (100 mg/kg, p.o.)-dosing group, the specific radioactivity in the marginal mucosa increased successively and significantly compared with the non-ulcerative mucosa. On the other hand, the incorporated radioactivity in the gastric mucosa reduced gradually at 24 or 48 hr after <SUP>14</SUP>C-glucosamine dosing and oral KU-54 at 100 mg/kg did not affect the rate of reduction of radioactivity in both the acid-soluble and the acid-insoluble fraction of the gastric mucosa.
- 社団法人 日本薬理学会の論文
著者
関連論文
- ラット酢酸胃潰瘍の再発,再燃に対するH_2受容体拮抗薬KU-1257の影響
- Troxipideの急性胃粘膜病変に対する効果
- Daunorubicinによる実験的ネフローゼラットにおける高脂血症の成因とKCD-232[4-(4-Chlorobenzyloxy)benzyl nicotinate]の作用
- 4-(4-Chlorobenzyloxy) benzyl nicotinate〔KCD-232〕の薬理学的研究 ラットおよびマウスの脂質代謝におよぼす影響
- 実験的ラット脳梗塞モデルに対するKC-404の効果
- KC-404のI-IV型アレルギー反応に対する作用
- KG404のアナフィラキシー性気道反応に対する作用
- 14C-Glucosamineの胃粘膜および肝組織への取込みとその消退に対する3,4,5-Trimethoxy-N-(3-piperidyl)benzamide(KU-54)の影響
- 3,4,5-Trimethoxy-N-(3-piperidyl)benzamide(KU-54)の胃粘膜,肝組織内呼吸におよぼす影響